Information about Eltrombopag
Eltrombopag is used for low platelet count due to ITP or HCV infection. It is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It’s also used to treat severe aplastic anemia.
How eltrombopag works
Eltrombopag is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. Platelets help to reduce or prevent bleeding.
Common side effects of eltrombopag
Nausea, Diarrhoea, Upper respiratory tract infection, Vomiting, Increased liver enzymes, Muscle pain, Urinary tract infection
Available Medicine for Eltrombopag
- ₹7100 to ₹14200Glaxo SmithKline Pharmaceuticals Ltd2 variant(s)
Expert advice for Eltrombopag
- Take Eltrombopag on an empty stomach, either 1 hour before or 2 hours after meals.
- Take Eltrombopag at least 2 hours before or 4 hours after eating dairy products and calcium-fortified juices.
Frequently asked questions for Eltrombopag
Q. Is Eltrombopag available in India?
Yes, Eltrombopag is available in India
Q. Is Eltrombopag approved by US FDA and available in India?
Yes, Eltrombopag is approved by US FDA and it is available in India.